tag genomic-testing 
The Pharma Data
NOVEMBER 29, 2021
1.1.529 a variant of concern, named Omicron, on the advice of WHO’s Technical Advisory Group on Virus Evolution (TAG-VE). The number of people testing positive has risen in areas of South Africa affected by this variant, but epidemiologic studies are underway to understand if it is because of Omicron or other factors.
The Pharma Data
MARCH 23, 2022
Polymerase is a viral protein that directs how Ebola virus replicates its genome as it infects new hosts. Back in 2018, researchers tested a broad-spectrum antiviral candidate called remdesivir/VEKLURY, which acts as a nucleotide decoy to get incorporated into the viral RNA genome and stop viral polymerase.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JUNE 29, 2022
For example, while orphan drug designations have more than doubled in the last decade compared to the previous one, only 16% of therapies with orphan tags have managed to gain FDA approval in some indications. Prior to the program, only 10 drugs were approved for a rare disease.
Delveinsight
FEBRUARY 25, 2021
Instead of snipping the genome, base editing lets for edits of individual letters in a genetic sequence. GRAIL and Quest collaborate for the cancer blood test. Through this pact with GRAIL, Quest’s phlebotomy network will benefit the Galleri test in blood specimen collection throughout the U.S.
The Pharma Data
OCTOBER 9, 2021
This designation is predicated on data showing that gantenerumab significantly reduced brain amyloid pillar, a pathological hallmark of Notice, in the ongoing SCarlet RoAD and Marguerite RoAD open- tag extension trials, as well as other studies. Source link: [link].
The Pharma Data
MARCH 20, 2021
Whether the scale of these labs is at the national level, processing hundreds of thousands of samples a day, through to small-scale and agile laboratories testing at an organizational level, there is a place in the workflow to accommodate automation. professor in Functional Cancer Genomics and Applied. The diagnostic test is run under.
pharmaphorum
DECEMBER 7, 2021
That finding could provide some comfort to Biogen and Eisai, whose recently-approved amyloid-targeting drug Aduhelm (aducanumab) is struggling to gain traction in the market on the back of unconvincing efficacy data, safety concerns and a high price tag.
Expert insights. Personalized for you.
52 
Let's personalize your content